Author:
Kim Garam,Bhattarai Poshan Yugal,Lim Sung-Chul,Lee Kwang Youl,Choi Hong Seok
Funder
National Research Foundation of Korea
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,Molecular Medicine,General Medicine
Reference57 articles.
1. M. Batus, S. Waheed, C. Ruby, L. Petersen, S.D. Bines, H.L. Kaufman, Optimal management of metastatic Melanoma: current strategies and future directions. Am. J. Clin. Dermatol. 14, 179–194 (2013)
2. A. Eggermont, Advances in systemic treatment of Melanoma. Ann. Oncol. 21, vii339–vii344 (2010)
3. L. Serrone, M. Zeuli, F.M. Sega, F. Cognetti, Dacarbazine-based chemotherapy for metastatic Melanoma: thirty-year experience overview. J. Exp. Clin. Cancer Res. 19, 21–34 (2000)
4. G. Jiang, R.H. Li, C. Sun, Y.Q. Liu, J.N. Zheng, Dacarbazine combined targeted therapy versus dacarbazine alone in patients with malignant Melanoma: a meta-analysis. PLoS One 9, e111920 (2014)
5. A. Knight, L. Karapetyan, J.M. Kirkwood, Immunotherapy in Melanoma: recent advances and future directions. Cancers (Basel) 15, (2023)
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献